Numerate's Ranking Technology for Pharmaceutical R&D Gains U.S. Patent

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc., a technology platform company that designs drug candidates to meet the specifications of its biotechnology and pharmaceutical partners, announced today the grant of U.S. Patent No. 7,702,467 B2, which provides patent protection for methods of using biological assay data to develop predictive models. These models have accuracies comparable to laboratory testing.